{"filing":{"accession_number":"0001193125-26-325031","cik":"0001816736","ticker":"IRON","company_name":"Disc Medicine, Inc.","form":"8-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"iron-20260730.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526325031/iron-20260730.htm"},"events":[{"id":22586,"run_id":20434,"accession_number":"0001193125-26-325031","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026. The filing discloses financial results including R\u0026D expenses ($46.9M), SG\u0026A expenses ($18.1M), net loss ($59.5M), and cash position ($717.7M), along with condensed consolidated statements of operations and balance sheets. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly covers \"Results of Operations and Financial Condition,\" which is the standard Item for earnings announcements.","company_name":"Disc Medicine, Inc.","ticker":"IRON","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22565,"accession_number":"0001193125-26-325031","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026. The filing discloses financial results including R\u0026D expenses ($46.9M), SG\u0026A expenses ($18.1M), net loss ($59.5M), and cash position ($717.7M), along with condensed consolidated statements of operations and balance sheets. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly covers \"Results of Operations and Financial Condition,\" which is the standard Item for earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:21:09.345622+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22565,"accession_number":"0001193125-26-325031","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026. The filing discloses financial results including R\u0026D expenses ($46.9M), SG\u0026A expenses ($18.1M), net loss ($59.5M), and cash position ($717.7M), along with condensed consolidated statements of operations and balance sheets. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly covers \"Results of Operations and Financial Condition,\" which is the standard Item for earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:21:09.345622+00:00","company_name":"Disc Medicine, Inc.","ticker":"IRON","filing_date":"2026-07-30"}]}